Physician profile
Gerald Vernon
NPI 1790851061
$486.21
in general payments reported to CMS, 2019-2025
8 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.41 · 2020: $127 · 2021: $55.53 · 2022: $32.23 · 2023: $64.04 · 2024: $18.01 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $104 · Food and Beverage: $82.05 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $104.46 |
| Food and Beverage | $82.05 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $202.65 | 2019-2024 | Orthovisc, Monovisc |
| Curonix LLC | $120.45 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Hydrocision, INC. | $37.02 | 2023 | Tenjet |
| Zimmer Biomet Holdings, INC. | $32.23 | 2022 | |
| Bioventus LLC | $27.70 | 2021 | |
| Organogenesis INC. | $27.02 | 2023 | Puraply |
| Trice Medical, INC. | $25.59 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $13.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Vernon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.